• 22 April 2022

Another international award for Natura Vitalis

Another international award for Natura Vitalis

Natura Vitalis was once again awarded the "Biotechnology Award". The award is for "Most Innovative Micelle Technology Manufacturer 2022".

For the seventh time, the British trade publication Global Health & Pharma is presenting its prestigious "Biotechnology Awards". These are designed to shine a spotlight on the pioneers and leading innovators in this important and constantly evolving sector. In short, with the "Biotechnology Awards", Global Health & Pharma honours companies from the pharmaceutical and healthcare sector that excel in biotechnology methods and thereby drive developments in the healthcare sector of the future. Regardless of size and scope, the 'Biotechnology Awards' are evaluated and judged solely on performance and excellence. In this way, the platform aims to ensure that only the most deserving, innovative and committed companies are awarded.

For the repeated time, the Essen-based company Natura Vitalis was awarded the 'Biotechnology Award'. The award is for "Most Innovative Micelle Technology Manufacturer 2022", i.e. the most innovative manufacturer of micelles in natural food supplements (https://www.ghp-news.com/winners/natura-vitalis-gmbh-3/). Natura Vitalis has regularly received international awards for its role as one of the leading manufacturers of natural food supplements for several years.

Micelles are small amphiphilic molecular vesicles that can bind water and fats, providing an important packaging for nutrients. The molecules coat fat-soluble substances so that they survive the passage through the stomach acid well. The nutrients thus pass undamaged across the intestinal membrane into the blood. "In this way, micelles increase the bioavailability of important nutrients. Bioavailability is a measure of the proportion of an active ingredient that is available unchanged in the systemic circulation, especially in the bloodstream. It therefore describes how quickly and to what extent the substance is absorbed and is available at the site of action," says Natura Vitalis founder Frank Felte (www.naturavitalis.de). The company places the highest value on continuous further and new developments of health products on a scientific basis. Natura Vitalis is currently developing a whole range of micelle products and wants to take a pioneering role on the German market with them - as with many other natural vital substances.

"We are of course very pleased to be back and to be among the top suppliers of natural food supplements and vital substances throughout Europe. It is a confirmation of our strategy to always combine innovation and quality and in this way create the best products for all health situations. This is rewarded with awards such as the 'Biotechnology Award'," says Frank Felte delightedly.

Global Health & Pharma says: "The year 2021 brought many threats to the health and well-being of millions of people around the world, and thanks to the developments and perseverance of the global biotechnology landscape, millions of people are able to live a full and healthy life. With impressive growth in market value and no signs of slowing down, the biotechnology sector continues to thrive as innovative solutions and breakthrough advances are developed in laboratories and boardrooms around the world. The Biotechnology Awards are proud to recognise and reward the innovative pioneers and dedicated leaders of the sector."

This text may contain translation errors as the translation was done by an online translation tool.